A vital jab?

February 2021

How could the COVID-19 vaccine affect your business? Slava Kiryushin and Joshua Coleman-Pecha of DWF consider the impact of compulsory inoculation on the organisation. On November 9, 2020, pharmaceutical companies Pfizer and BioNTech were the first to announce that they had developed a COVID-19 vaccine that was over 90 per cent effective at Phase 3 (efficacy testing) stage. Since then,...

To continue reading this article, Existing users can sign in / subscribe / renew and new users are requested to register.

May 2024

ICCA Congress 2024 Hong Kong - ‘International Arbitration: A Human Endeavour’

05 - 08 May 2024

ICCA's biennial Congresses attract a large number of participants from across the globe and have made significant contributions to the development of dispute resolution theory and practice. Renowned for stimulating in-depth discussion and providing new insights on matters related to international arbitration, the ICCA Congress is the largest regular conference devoted to international arbitration and caters to both practitioners looking to build a practice in international arbitration and experts in the arbitration community.

	Cover Story
	POWERING THE FUTURE
	An analysis of the EU approach to the more sustainable eFuel sector.
	Digital Version

A vital jab?

Previous Editions